AMGN
Transfer...
 Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Classic Growth
# of Employee: 17,900 / Fiscal Year End: 2016-12-31 / Stock Type: Large Core
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Amgen Inc is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. The Company's business segment is human therapeutics.

Competitors | AnnualReport

Competitors List | Key Matrix Details

NVO | GILD | CELG | BIIB | SHPG | VRTX | REGN | ALXN | GRFS | INCY | NKTR | AKCA |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2014-06-25Quarter5,180m1,081m282m1,547m1,547m768,000,k79.10%29.90%29.90%
2014-09-25Quarter5,031m1,068m0.01,244m1,244m771,000,k78.80%24.70%24.70%
2014-12-25Quarter5,331m1,183m0.01,294m1,294m773,000,k77.80%24.30%24.30%
2015-03-25Quarter5,033m1,033m252m1,623m1,623m770,000,k79.50%32.20%32.20%
2015-06-25Quarter5,370m1,089m0.01,653m1,653m768,000,k79.70%30.80%30.80%
2015-09-25Quarter5,723m1,034m0.01,863m1,863m764,000,k81.90%32.60%32.60%
2015-12-25Quarter5,536m1,071m0.01,800m1,800m763,000,k80.70%32.50%32.50%
2016-03-25Quarter5,527m1,018m294m1,900m1,900m760,000,k81.60%34.40%34.40%
2016-06-25Quarter5,688m1,050m0.01,870m1,870m756,000,k81.50%32.90%32.90%
2016-09-25Quarter5,811m1,027m0.02,017m2,017m753,000,k82.30%34.70%34.70%
2016-12-25Quarter5,965m1,067m328m1,935m1,935m742,000,k82.10%32.40%32.40%
2017-03-25Quarter5,464m996m326m2,071m2,071m741,000,k81.80%37.90%37.90%
2017-06-25Quarter5,810m1,024m321m2,151m2,151m738,000,k82.40%37.00%37.00%
2017-09-25Quarter5,773m990m325m2,021m2,021m733,000,k82.90%35.00%35.00%
2017-12-25Quarter5,802m1,059m332m-4,264m-4,264m726,000,k81.70%-73.50%-73.50%
2018-03-25Quarter5,554m944m338m2,311m2,311m711,000,k83.00%41.60%41.60%
2018-06-25Quarter6,059m1,024m347m2,296m2,296m660,000,k83.10%37.90%37.90%
2018-09-25Quarter5,904m1,037m355m1,859m1,859m649,000,k82.40%31.50%31.50%
2018-12-25Quarter6,230m1,096m352m1,928m1,928m641,000,k82.40%30.90%30.90%
2019-03-25Quarter5,557m1,055m343m1,992m1,992m626,000,k81.00%35.80%35.80%
2019-06-25Quarter5,871m1,012m332m2,179m2,179m610,000,k82.80%37.10%37.10%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2015-06-25Quarter3.67%0.74%-100.00%6.85%6.85%0.00%0.76%3.01%3.01%
2015-09-25Quarter13.75%-3.18%0.00%49.76%49.76%-0.91%3.93%31.98%31.98%
2015-12-25Quarter3.85%-9.47%0.00%39.10%39.10%-1.29%3.73%33.74%33.74%
2016-03-25Quarter9.82%-1.45%16.67%17.07%17.07%-1.30%2.64%6.83%6.83%
2016-06-25Quarter5.92%-3.58%0.00%13.13%13.13%-1.56%2.26%6.82%6.82%
2016-09-25Quarter1.54%-0.68%0.00%8.27%8.27%-1.44%0.49%6.44%6.44%
2016-12-25Quarter7.75%-0.37%0.00%7.50%7.50%-2.75%1.73%-0.31%-0.31%
2017-03-25Quarter-1.14%-2.16%10.88%9.00%9.00%-2.50%0.25%10.17%10.17%
2017-06-25Quarter2.14%-2.48%0.00%15.03%15.03%-2.38%1.10%12.46%12.46%
2017-09-25Quarter-0.65%-3.60%0.00%0.20%0.20%-2.66%0.73%0.86%0.86%
2017-12-25Quarter-2.73%-0.75%1.22%-320.36%-320.36%-2.16%-0.49%-326.85%-326.85%
2018-03-25Quarter1.65%-5.22%3.68%11.59%11.59%-4.05%1.47%9.76%9.76%
2018-06-25Quarter4.29%0.00%8.10%6.74%6.74%-10.57%0.85%2.43%2.43%
2018-09-25Quarter2.27%4.75%9.23%-8.02%-8.02%-11.46%-0.60%-10.00%-10.00%
2018-12-25Quarter7.38%3.49%6.02%-145.22%-145.22%-11.71%0.86%-142.04%-142.04%
2019-03-25Quarter0.05%11.76%1.48%-13.80%-13.80%-11.95%-2.41%-13.94%-13.94%
2019-06-25Quarter-3.10%-1.17%-4.32%-5.10%-5.10%-7.58%-0.36%-2.11%-2.11%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter29,875m77,626m47,751m46,010m11,204m36,547m.626.244
2017-03-25Quarter30,637m77,862m47,225m46,456m10,523m36,702m.649.227
2017-06-25Quarter31,722m79,587m47,865m48,442m7,815m40,050m.663.161
2017-09-25Quarter32,229m80,331m48,102m49,752m8,193m39,909m.670.165
2017-12-25Quarter25,241m79,954m54,713m49,476m9,020m45,693m.461.182
2018-03-25Quarter15,620m71,164m55,544m40,689m10,479m45,065m.281.258
2018-06-25Quarter14,909m67,684m52,775m37,970m11,205m41,570m.283.295
2018-09-25Quarter14,349m67,333m52,984m38,320m12,432m40,552m.271.324
2018-12-25Quarter12,500m66,416m53,916m37,618m13,488m40,428m.232.359
2019-03-25Quarter10,832m63,997m53,165m35,151m12,706m40,459m.204.361

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter-15.51%3.00%14.58%7.53%-19.49%25.03%-26.36%-25.41%
2018-03-25Quarter-49.02%-8.60%17.62%-12.41%-0.42%22.79%-56.70%13.66%
2018-06-25Quarter-53.00%-14.96%10.26%-21.62%43.38%3.80%-57.32%83.23%
2018-09-25Quarter-55.48%-16.18%10.15%-22.98%51.74%1.61%-59.55%96.36%
2018-12-25Quarter-50.48%-16.93%-1.46%-23.97%49.53%-11.52%-49.67%97.25%
2019-03-25Quarter-30.65%-10.07%-4.28%-13.61%21.25%-10.22%-27.40%39.92%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note